Alport syndrome: a unified classification of genetic disorders of collagen IV α345: a position paper of the Alport Syndrome Classification Working Group CE Kashtan, J Ding, G Garosi, L Heidet, L Massella, K Nakanishi, K Nozu, ... Kidney international 93 (5), 1045-1051, 2018 | 302 | 2018 |
Distinct target-derived signals organize formation, maturation, and maintenance of motor nerve terminals MA Fox, JR Sanes, DB Borza, VP Eswarakumar, R Fässler, BG Hudson, ... Cell 129 (1), 179-193, 2007 | 299 | 2007 |
Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research Collaborative CE Kashtan, J Ding, M Gregory, O Gross, L Heidet, B Knebelmann, ... Pediatric nephrology 28, 5-11, 2013 | 177 | 2013 |
The evolution of the journal club: from Osler to Twitter JM Topf, MA Sparks, PJ Phelan, N Shah, EV Lerma, MPM Graham-Brown, ... American Journal of Kidney Diseases 69 (6), 827-836, 2017 | 165 | 2017 |
HLA-DQA1 and PLCG2 are candidate risk loci for childhood-onset steroid-sensitive nephrotic syndrome RA Gbadegesin, A Adeyemo, NJA Webb, LA Greenbaum, ... Journal of the American Society of Nephrology 26 (7), 1701-1710, 2015 | 140 | 2015 |
Alport syndrome in women and girls J Savige, D Colville, M Rheault, S Gear, R Lennon, S Lagas, M Finlay, ... Clinical Journal of the American Society of Nephrology 11 (9), 1713-1720, 2016 | 136 | 2016 |
Mouse model of X-linked Alport syndrome MN Rheault, SM Kren, BK Thielen, HA Mesa, JT Crosson, W Thomas, ... Journal of the American Society of Nephrology 15 (6), 1466-1474, 2004 | 136 | 2004 |
The social media revolution in nephrology education GB Colbert, J Topf, KD Jhaveri, T Oates, MN Rheault, S Shah, S Hiremath, ... Kidney international reports 3 (3), 519-529, 2018 | 121 | 2018 |
AKI in children hospitalized with nephrotic syndrome MN Rheault, L Zhang, DT Selewski, M Kallash, CL Tran, M Seamon, ... Clinical Journal of the American Society of Nephrology 10 (12), 2110-2118, 2015 | 120 | 2015 |
Sound science before quick judgement regarding RAS blockade in COVID-19 MA Sparks, A South, P Welling, JM Luther, J Cohen, JB Byrd, LM Burrell, ... Clinical Journal of the American Society of Nephrology 15 (5), 714-716, 2020 | 102 | 2020 |
Women and Alport syndrome MN Rheault Pediatric Nephrology 27 (1), 41-46, 2012 | 97 | 2012 |
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial HJL Heerspink, J Radhakrishnan, CE Alpers, J Barratt, S Bieler, U Diva, ... The Lancet 401 (10388), 1584-1594, 2023 | 85 | 2023 |
CureGN study rationale, design, and methods: establishing a large prospective observational study of glomerular disease LH Mariani, AS Bomback, PA Canetta, MF Flessner, M Helmuth, ... American journal of kidney diseases 73 (2), 218-229, 2019 | 81 | 2019 |
IgA nephropathy presenting as macroscopic hematuria in 2 pediatric patients after receiving the Pfizer COVID-19 vaccine C Hanna, LPH Hernandez, L Bu, S Kizilbash, L Najera, MN Rheault, ... Kidney international 100 (3), 705-706, 2021 | 73 | 2021 |
Advances and unmet needs in genetic, basic and clinical science in Alport syndrome: report from the 2015 International Workshop on Alport Syndrome O Gross, CE Kashtan, MN Rheault, F Flinter, J Savige, JH Miner, R Torra, ... Nephrology Dialysis Transplantation 32 (6), 916-924, 2017 | 72 | 2017 |
Reversible Fanconi syndrome in a pediatric patient on deferasirox MN Rheault, H Bechtel, JP Neglia, CE Kashtan Pediatric blood & cancer 56 (4), 674-676, 2011 | 64 | 2011 |
X-inactivation modifies disease severity in female carriers of murine X-linked Alport syndrome MN Rheault, SM Kren, LA Hartich, M Wall, W Thomas, HA Mesa, P Avner, ... Nephrology Dialysis Transplantation 25 (3), 764-769, 2010 | 63 | 2010 |
Clinical characteristics and treatment patterns of children and adults with IgA nephropathy or IgA vasculitis: findings from the CureGN study DT Selewski, JM Ambruzs, GB Appel, AS Bomback, RB Matar, Y Cai, ... Kidney international reports 3 (6), 1373-1384, 2018 | 62 | 2018 |
Role of direct oral anticoagulants in patients with kidney disease VK Derebail, MN Rheault, BA Kerlin Kidney international 97 (4), 664-675, 2020 | 61 | 2020 |
One-year mortality rates in US children with end-stage renal disease BM Chavers, JT Molony, CA Solid, MN Rheault, AJ Collins American journal of nephrology 41 (2), 121-128, 2015 | 60 | 2015 |